Clinical trial Recruiting at 1 site Observational Ages 19 and up

Ring-style blood pressure bracelet test compared with 24-hour monitoring in people with HFrEF

Official title: Feasibility and Effectiveness of a RING-type Blood Pressure Measurement Device (CART-BP) Compared With 24-Hour Ambulatory Blood Pressure Monitoring Device in Patients With Heart Failure With Reduced Ejection Fraction (RING-HFrEF)

Run by Keimyung University Dongsan Medical Center · NCT07626879 · Data updated 2026-11-12

A ring-type blood pressure device is being tested to see if its 24-hour readings match those from standard ambulatory monitoring in adults with heart failure and reduced ejection fraction.

More Hypertension trials

Quick facts

Study typeObservational
Ages19 Years and up
SexAll
Enrollment100 (estimated)
SponsorKeimyung University Dongsan Medical Center
Academic / other
Drugs / interventionsCART
Locations1 site (Daegu)
StatusRecruiting
StartedOctober 23, 2025
Main results expectedOctober 22, 2026
Study endsOctober 22, 2026
Registry record updatedJune 4, 2026
Trial IDNCT07626879 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 19 years or older with diagnosed HFrEF (LVEF ≤ 40%), able to wear the ring device and participate in 24-hour monitoring.

Probably not a fit

Patients with very abnormal office BP or those unable to perform 24-hour monitoring or wear the device may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational, multi-center study in South Korea compares a ring-based BP device that uses photoplethysmography (PPG) to the conventional 24-hour ABPM. Fifty? No, 100 patients will be enrolled to measure BP over a full day and assess agreement with ISO 81060-2:2018 criteria for mean, daytime, and nighttime values. An interim analysis after 40 participants will determine whether to continue to the full enrollment. The study focuses on ensuring accuracy in a population where BP readings can be challenging due to reduced cardiac output and vascular changes.

Why it matters

Potential benefit: If successful, the ring device could offer continuous, comfortable BP monitoring for patients with HFrEF, potentially improving BP management.

How similar studies have gone: Previous BP monitoring work with wearable or ring-based devices has shown variable accuracy; this study tests a specific ring device against standard ABPM in HFrEF.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 19 years (male or female)
2. Diagnosed with heart failure and currently under treatment
3. Left ventricular ejection fraction (LVEF) ≤ 40% confirmed by echocardiography performed within 1 year prior to enrollment
4. Able to undergo both 24-hour ambulatory blood pressure monitoring and ring-type blood pressure measurement
5. Voluntarily provided written informed consent to participate in this clinical study

Exclusion Criteria:

1. Office blood pressure: SBP \< 90 mmHg, or DBP \< 50 mmHg, or SBP \> 180 mmHg, or DBP \> 100 mmHg
2. Unable to perform 24-hour ambulatory blood pressure monitoring
3. Unable to wear or use the ring-type blood pressure device
4. Variability in three consecutive resting cuff blood pressure measurements ≥ 20 mmHg (SBP) or ≥ 10 mmHg (DBP)
5. Insufficient valid ABPM readings: \< 25 daytime or \< 12 nighttime measurements per ESH criteria; or \< 25 daytime or \< 12 nighttime valid readings from the ring-type device
6. Pregnant, suspected pregnancy, or breastfeeding
7. Judged by the investigator to be legally or mentally unfit to participate in the clinical study

Where it's running

  • Keimyung University Dongsan Medical Center
    Daegu, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.